Cuba approves two more locally made COVID vaccines

Comments Off on Cuba approves two more locally made COVID vaccines

Cuba on Friday approved two more domestic COVID-19 vaccines for emergency use, the island nation’s medication regulatory body said. The authorization came after a “rigorous evaluation process of the Soberana 02 and Soberana Plus vaccines,”

FDA Approves Ticovac

Comments Off on FDA Approves Ticovac

FDA Approves TicoVac (tick-borne encephalitis vaccine) to Prevent Tick-Borne Encephalitis (TBE) NEW YORK–(BUSINESS WIRE) August 13, 2021 — Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved TicoVac (tick-borne

FDA Approves Aduhelm

Comments Off on FDA Approves Aduhelm

FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that

FDA Approves Pylarify

Comments Off on FDA Approves Pylarify

FDA Approves Pylarify (piflufolastat F 18) PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer May 27, 2021 — FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of

FDA Approves Fotivda

Comments Off on FDA Approves Fotivda

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and

Australia approves Pfizer vaccine for rollout in February

Comments Off on Australia approves Pfizer vaccine for rollout in February

Australia’s medical regulator has formally approved the Pfizer COVID-19 vaccine, with the first doses expected to be administered in late February, Prime Minister Scott Morrison announced Monday. The Therapeutic Goods Administration (TGA) granted provisional approval

FDA Approves Sesquient

Comments Off on FDA Approves Sesquient

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S.